Specialties
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Classics™
COVID Central
Rewinds
Click for the Rewinds Archive
Write for Us
Writer Application
Submit an Opinion
Subscribe
For Partners
License Content
Submit Press Release
Advertise with Us
Account
Register
Sign-In
Manage Subscriptions
Search
Tuesday, February 23, 2021
About
Masthead
License Content
Advertise
Submit Press Release
RSS/Email List
Write for us
Contact us
2 Minute Medicine
Specialties
All
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Azithromycin does not reduce mortality in patients hospitalized with COVID-19
Antibiotic prophylaxis for UTIs in elderly patients associated with an increased…
Limiting On-Call Hours Improves Resident-Physicians’ Neurobehavioral Performance
Early head-to-pelvis CT imaging for patients experiencing out-of-hospital circulatory arrest is…
Classics™
COVID Central
Rewinds
2 Minute Medicine Rewind February 22, 2021
2 Minute Medicine Rewind February 8, 2021
2 Minute Medicine Rewind Jan 25, 2021
2 Minute Medicine Rewind January 25, 2021
2 Minute Medicine Rewind January 18, 2021
Click for the Rewinds Archive
Write for Us
Writer Application
Submit an Opinion
Subscribe
For Partners
License Content
Submit Press Release
Advertise with Us
Account
Register
Sign-In
Manage Subscriptions
Tag: blood
#VisualAbstract Phase I: Adding carfilzomib to HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia showed favourable safety and efficacy outcomes
Kathleen Lau
-
February 19, 2021
0
Read more
#VisualAbstract Bortezomib, cyclophosphamide, and dexamethasone demonstrated a modest median event-free survival in transplant ineligible patients with multiple myeloma
Kathleen Lau
-
February 18, 2021
0
Read more
#VisualAbstract Low-PV study: Adding ropeginterferon alfa-2b to phlebotomy and aspirin shows improvement in response rates for treatment of polycythaemia vera in low-risk patients
Kathleen Lau
-
February 12, 2021
0
Read more
#VisualAbstract Multiple Cereblon genetic alterations were associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma
Kathleen Lau
-
February 11, 2021
0
Read more
#VisualAbstract Higher risk of mortality during COVID-19 infection among patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib at COVID-19 diagnosis
Kathleen Lau
-
January 29, 2021
0
Read more
#VisualAbstract Lenalidomide shows improvement in progression-free survival over bortezomib maintenance following autologous stem cell transplantation for multiple myeloma
Kathleen Lau
-
January 28, 2021
0
Read more
#VisualAbstract AMLSG 09-09: Adding getuzumab ozogamicin (GO) to intensive therapy for Nucleophosmin1 mutated acute myeloid leukemia (NPM1mut AML) leads to better NPM1mut transcript clearance and a lower replase rate
Kathleen Lau
-
January 15, 2021
0
Read more
#VisualAbstract Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)
Kathleen Lau
-
January 8, 2021
0
Read more
#VisualAbstract Administering bortezomib on a weekly basis VS twice weekly basis does not significantly affect progression-free survival (PFS) or overall survival (OS) in Vrd first-line therapy for multiple myeloma...
Kathleen Lau
-
January 1, 2021
0
Read more
#VisualAbstract DIVERSITY trial: Dabigatran etexilate was non-inferior to standard of care in effectively treating acute venous thromboembolism (VTE) in children
Kathleen Lau
-
December 31, 2020
0
Read more
1
2
Page 1 of 2
